Bernhard Ehmer
Chairman
Management
biotest
Germany
Biography
Dr. Bernhard Ehmer is Chairman of the Management Board of Biotest Aktiengesellschaft since January 1, 2015. Previously, he served as Member of the Management Board of the Company from November 1, 2014. He got a Ph.D. in Medicine and was resident in internal medicine at a teaching hospital of the University of Heidelberg, before he started his career in the pharmaceutical industry first with Boehringer Mannheim, then with Merck KGaA. Later he was CEO of Fresenius Biotech GmbH before he joined Imclone Systems Corp. In his last position as CEO & President of Imclone Systems Corp. his focus has been in the clinical development and market preparation of biologic pharmaceuticals. Finally he integrated most of the key functions of Imclone Systems into the organization of Eli Lilly, the parent company of Imclone Systems. Dr. Cathrin S
Research Interest
Pharma chemicals Phrmaceuticals
